Dietary supplementation with Lovaza and krill oil shortens the life span of long-lived F1 mice

详细信息    查看全文

• 作者：Stephen R. Spindler (1)
  Patricia L. Mote (1)
  James M. Flegal (2)
  
• 关键词：ω ; 3 Fatty acids ; Lovaza ; Krill oil ; Marine oil ; Mice ; Life span ; Longevity
• 刊名：AGE
• 出版年：2014
• 出版时间：June 2014
• 年：2014
• 卷：36
• 期：3
• 全文大小：283 KB
• 参考文献：1. Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, Kovalenko IG, Poroshina TE, Semenchenko AV, Provinciali M, Re F, Franceschi C (2005a) Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol 40:685-93 CrossRef
  2. Anisimov VN, Egormin PA, Bershtein LM, Zabezhinskii MA, Piskunova TS, Popovich IG, Semenchenko AV (2005b) Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice. Bull Exp Biol Med 139:721-23 CrossRef
  3. Bassett JK, Severi G, Hodge AM, Macinnis RJ, Gibson RA, Hopper JL, English DR, Giles GG (2013) Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer 133:188291. doi:10.1002/ijc.28203 CrossRef
  4. Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR (2013) Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 105:1132-141 CrossRef
  5. Calder PC, Yaqoob P (2012) Marine omega-3 fatty acids and coronary heart disease. Curr Opin Cardiol 27:412-19 CrossRef
  6. De Caterina R (2011) n-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439-450 CrossRef
  7. Dhahbi JM, Kim HJ, Mote PL, Beaver RJ, Spindler SR (2004) Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc Natl Acad Sci USA 101:5524-529 CrossRef
  8. GlaxoSmithKline (2013) GSK medical professional information: adverse reactions. http://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=ProductDetailPage&product_id=1336506912652&featureKey=603462#section-34084-4
  9. Hersher R (2012) Are drugmakers fishing for a market with prescription omega-3?s? Nat Med 18(1):6 CrossRef
  10. Jeske DR, Flegal J, Spindler SR (2014) Minimum size survival analysis sampling plans for comparing multiple treatment groups to a single control group. Commun Stat Theory Methods 43:9 CrossRef
  11. Kar S (2011) Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects. Am J Ther 21:56-6 CrossRef
  12. Kromhout D, Giltay EJ, Geleijnse JM (2010) n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363(21):2015-026 CrossRef
  13. Kwak SM, Myung SK, Lee YJ, Seo HG, Korean Meta-analysis Study Group (2012) Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 172(9):686-94 CrossRef
  14. Marchioli R, Barzi F, Bomba E, Chieffo C, Di GD, Di MR, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 105(16):1897-903 CrossRef
  15. Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin MJ, Schwab M, Pollak M, Zhang Y, Yu Y, Becker KG, Bohr VA, Ingram DK, Sinclair DA, Wolf NS, Spindler SR, Bernier M, de Cabo R (2013) Metformin improves healthspan and lifespan in mice. Nat Commun 4:2192 CrossRef
  16. Mozaffarian D, Wu JH (2012) (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr 142(3):614S-25S CrossRef
  17. ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Diaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Ryden LE, Yusuf S (2012) n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367:309-18 CrossRef
  18. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-951
  19. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308:1024-033 CrossRef
  20. Rustan AC, Christiansen EN, Drevon CA (1992) Serum lipids, hepatic glycerolipid metabolism and peroxisomal fatty acid oxidation in rats fed omega-3 and omega-6 fatty acids. Biochem J 283(Pt 2):333-39
  21. Ruzickova J, Rossmeisl M, Prazak T, Flachs P, Sponarova J, Veck M, Tvrzicka E, Bryhn M, Kopecky J (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39(12):1177-185 CrossRef
  22. Sano Y, Sato K, Uchida M, Murata M (2003) Blood coagulation and fibrinolysis of rats fed fish oil: reduced coagulation factors especially involved in intrinsic pathway and increased activity of plasminogen activator inhibitor. Biosci Biotechnol Biochem 67:2100-105 CrossRef
  23. Schwerbrock NM, Karlsson EA, Shi Q, Sheridan PA, Beck MA (2009) Fish oil-fed mice have impaired resistance to influenza infection. J Nutr 139:1588-594 CrossRef
  24. Spindler SR (2005) Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction. Mech Ageing Dev 126(9):960-66 CrossRef
  25. Spindler SR (2012) Review of the literature and suggestions for the design of rodent survival studies for the identification of compounds that increase health and life span. Age (Dordr) 34:111-20 CrossRef
  26. Spindler SR, Mote PL (2007) Screening candidate longevity therapeutics using gene-expression arrays. Gerontology 53:306-21 CrossRef
  27. Spindler SR, Mote PL, Flegal JM, Teter B (2013a) Influence on longevity of blueberry, cinnamon, green and black tea, pomegranate, sesame, curcumin, morin, pycnogenol, quercetin and taxifolin fed isocalorically to long-lived, F1 hybrid mice. Rejuvenation Res 16:143-51 CrossRef
  28. Spindler SR, Mote PL, Li R, Dhahbi JM, Yamakawa A, Flegal JM, Jeske DR, Li R, Lublin AL (2013b) β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice. Age (Dordr) 35:2099-109 CrossRef
  29. Spindler SR, Mote PL, Flegal JM (2014) Lifespan effects of simple and complex nutraceutical combinations fed isocalorically to mice. Age (Dordr) 36:705-18 CrossRef
  30. Tandy S, Chung RW, Wat E, Kamili A, Berge K, Griinari M, Cohn JS (2009) Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice. J Agric Food Chem 57(19):9339-345 CrossRef
  31. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372(9645):1223-230 CrossRef
  32. Tsuduki T, Honma T, Nakagawa K, Ikeda I, Miyazawa T (2011) Long-term intake of fish oil increases oxidative stress and decreases lifespan in senescence-accelerated mice. Nutrition 27:334-37 CrossRef
  33. Turunen AW, Mannisto S, Kiviranta H, Marniemi J, Jula A, Tiittanen P, Suominen-Taipale L, Vartiainen T, Verkasalo PK (2010) Dioxins, polychlorinated biphenyls, methyl mercury and omega-3 polyunsaturated fatty acids as biomarkers of fish consumption. Eur J Clin Nutr 64(3):313-23 CrossRef
  34. Vigerust NF, Bjorndal B, Bohov P, Brattelid T, Svardal A, Berge RK (2012) Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-alpha. Eur J Nutr 52(4):1315-325 CrossRef
  35. Woodworth HL, McCaskey SJ, Duriancik DM, Clinthorne JF, Langohr IM, Gardner EM, Fenton JI (2010) Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis. Cancer Res 70(20):7960-969 CrossRef
  36. Xia S, Li X, Cheng L, Han M, Zhang M, Liu X, Xu H, Zhang M, Shao Q, Qi L (2014) Chronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth. Cancer Immunol Immunother [Epub ahead of print]
  37. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369(9567):1090-098 CrossRef
  38. Zhang YF, Gao HF, Hou AJ, Zhou YH (2014) Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trials. BMC Public Health 14:204 CrossRef
  39. Zheng JS, Hu XJ, Zhao YM, Yang J, Li D (2013) Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 346:f3706. doi:10.1136/bmj.f3706 CrossRef
  
• 作者单位：Stephen R. Spindler (1)
  Patricia L. Mote (1)
  James M. Flegal (2)
  
  1. Department of Biochemistry, University of California at Riverside, Riverside, CA, 92521, USA
  2. Department of Statistics, University of California at Riverside, Riverside, CA, 92521, USA
  
• ISSN：1574-4647

文摘

Marine oils rich in ω-3 polyunsaturated fatty acids have been recommended as a preventive treatment for patients at risk for cardiovascular diseases. These oils also are the third most consumed dietary supplement in the USA. However, evidence for their health benefits is equivocal. We tested the daily, isocaloric administration of krill oil (1.17?g oil/kg diet) and Lovaza (Omacor; 4.40?g/kg diet), a pharmaceutical grade fish oil, beginning at 12?months of age, on the life span and mortality-related pathologies of long-lived, male, B6C3F1 mice. The oils were incorporated into the chemically defined American Institute of Nutrition (AIN)-93?M diet. An equivalent volume of soybean oil was removed. Krill oil was 3?% and Lovaza 11?% of the oil in the diets. When their effects were analyzed together, the marine oils significantly shortened life span by 6.6?% (P--.0321; log-rank test) relative to controls. Individually, Lovaza and krill oil non-significantly shortened median life span by 9.8 and 4.7?%, respectively. Lovaza increased the number of enlarged seminal vesicles (7.1-fold). Lovaza and krill oil significantly increased lung tumors (4.1- and 8.2-fold) and hemorrhagic diathesis (3.9- and 3.1-fold). Analysis of serum from treated mice found that Lovaza slightly increased blood urea nitrogen, while krill oil modestly increased bilirubin, triglycerides, and blood glucose levels. Taken together, the results do not support the idea that the consumption of isolated ω-3 fatty acid-rich oils will increase the life span or health of initially healthy individuals.